Copyright
©The Author(s) 2025.
World J Cardiol. Feb 26, 2025; 17(2): 99074
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.99074
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.99074
Table 3 Procedural outcomes and intraprocedural complications of deferred stenting, n (%)
Characteristics | Patients with STEMI |
Procedural outcomes for all patients | |
Hospital course | |
Uneventful | 33 (60) |
AF | 1 (1.8) |
CHB | 3 (5.4) |
Death | 1 (1.8) |
Hypotension | 8 (14.5) |
LVF | 5 (9) |
LVF, AF | 2 (3.6) |
VT | 2 (3.6) |
Intraprocedural complications in patients with deferred stenting | |
No complications | 46 (85.19) |
Slow/no-reflow after PCI | |
Slow-reflow | 4 (7.41) |
No-reflow | 4 (7.41) |
No | 46 (85.19) |
MACE | |
Bradycardia | 1 (1.85) |
CHB | 1 (1.85) |
Hypotension | 4 (7.41) |
LVF | 1 (1.85) |
VT | 1 (1.85) |
- Citation: Pradhan A, Uppal S, Vishwakarma P, Singh A, Bhandari M, Shukla A, Sharma A, Chaudhary G, Chandra S, Sethi R, Dwivedi SK. Outcomes of patients with acute ST-segment elevation myocardial infarction treated by a prolonged “Deferred” percutaneous coronary intervention strategy. World J Cardiol 2025; 17(2): 99074
- URL: https://www.wjgnet.com/1949-8462/full/v17/i2/99074.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i2.99074